ZANELLO, ANDREA
ZANELLO, ANDREA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.002 secondi).
Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties
2024 Bortolotti, Massimo; Biscotti, Francesco; Zanello, Andrea; Polito, Letizia; Bolognesi, Andrea
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents
2023 Bortolotti M.; Biscotti F.; Zanello A.; Bolognesi A.; Polito L.
Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy
2023 Massimo Bortolotti, Andrea Zanello, Lorenzo Serra, Francesco Biscotti, Letizia Polito, Andrea Bolognesi
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
2022 Zanello A.; Bortolotti M.; Maiello S.; Bolognesi A.; Polito L.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties | Bortolotti, Massimo; Biscotti, Francesco; Zanello, Andrea; Polito, Letizia; Bolognesi, Andrea | 2024-01-01 | TOXINS | - | 1.01 Articolo in rivista | 2024 toxins.pdf |
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents | Bortolotti M.; Biscotti F.; Zanello A.; Bolognesi A.; Polito L. | 2023-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | 20223 biomedicines.pdf |
Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy | Massimo Bortolotti, Andrea Zanello, Lorenzo Serra, Francesco Biscotti, Letizia Polito, Andrea Bol...ognesi | 2023-01-01 | STRESSES | - | 1.01 Articolo in rivista | 50_Bortolotti et al_Stresses_2023.pdf |
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? | Zanello A.; Bortolotti M.; Maiello S.; Bolognesi A.; Polito L. | 2022-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | 2022 FPhar-antiPD-L1.pdf |